On this site you will find clinical studies with cannabis or single
cannabinoids in different diseases and case reports on the use of cannabis by
You may search for diseases (indications), authors, medication, study design (controlled study, open trial, case report etc.) and other criteria.
|Title||Long-term effectiveness and safety of nabiximols (tetrahydrocannabinol/cannabidiol oromucosal spray) in clinical practice.|
|Author(s)||Flachenecker P, Henze T, Zettl UK.|
|Journal, Volume, Issue||Eur Neurol 2014;72(1-2):95-102.|
|Major outcome(s)||Researchers found that ôreal-life data confirm the long-term effectiveness and tolerability of nabiximols [Sativex] for the treatment of resistant MSS [multiple sclerosis spasticity].|
BACKGROUND: Nabiximols (Sativex®), in a cannabinoid-based oromucosal spray, is an add-on therapy option for patients with moderate to severe multiple sclerosis spasticity (MSS) resistant to other medications. The study objective was to provide long-term data on clinical outcomes, tolerability, quality of life and treatment satisfaction for MSS patients receiving nabiximols in routine care.
|Participants||52 patients with multiple sclerosis|
|Type of publication||Medical journal|
|Address of author(s)||Neurological Rehabilitation Centre Quellenhof, Bad Wildbad, Germany.|